These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
117 related articles for article (PubMed ID: 3455064)
1. Improved bone formation in dialysis patients after substitution of calcium carbonate for aluminum gels. Hercz G; Andress DL; Norris KC; Shinaberger JH; Slatopolsky EA; Sherrard DJ; Coburn JW Trans Assoc Am Physicians; 1987; 100():139-46. PubMed ID: 3455064 [No Abstract] [Full Text] [Related]
2. Changes in bone histology after treatment with desferrioxamine. Ott SM; Andress DL; Nebeker HG; Milliner DS; Maloney NA; Coburn JW; Sherrard DJ Kidney Int Suppl; 1986 Feb; 18():S108-13. PubMed ID: 3457986 [No Abstract] [Full Text] [Related]
3. Aluminum and renal bone disease in Australia. Dunstan CR; Evans RA Kidney Int Suppl; 1986 Feb; 18():S65-9. PubMed ID: 3457999 [No Abstract] [Full Text] [Related]
4. Aluminum-related osteomalacia in renal-failure patients. Vick KE; Johnson CA Clin Pharm; 1985; 4(4):434-9. PubMed ID: 3899471 [TBL] [Abstract][Full Text] [Related]
5. Experience with aluminum-associated bone disease in end-stage renal disease patients. Joglar FM; Rivera CG; Burgos R; Huffer WE Transplant Proc; 1991 Apr; 23(2):1823-4. PubMed ID: 2053166 [No Abstract] [Full Text] [Related]
6. Role of plasma aluminum in the detection and prevention of aluminum toxicity. Winney RJ; Cowie JF; Robson JS Kidney Int Suppl; 1986 Feb; 18():S91-5. PubMed ID: 3458005 [No Abstract] [Full Text] [Related]
7. [Long term CaCO3 treatment of chronic hemodialysis patients--an attempt to prevent and treat aluminum osteopathy]. Matsubara M; Totsune K; Saito T; Yoshinaga K; Unagami H; Sato H Nihon Jinzo Gakkai Shi; 1988 Nov; 30(11):1349-54. PubMed ID: 3236516 [No Abstract] [Full Text] [Related]
8. Osteomalacia and bone disease arising from aluminum. Coburn JW; Norris KC; Nebeker HG Semin Nephrol; 1986 Mar; 6(1):68-89. PubMed ID: 3110896 [No Abstract] [Full Text] [Related]
9. Reversal of aluminum-related bone disease after substituting calcium carbonate for aluminum hydroxide. Hercz G; Andress DL; Nebeker HG; Shinaberger JH; Sherrard DJ; Coburn JW Am J Kidney Dis; 1988 Jan; 11(1):70-5. PubMed ID: 3337101 [TBL] [Abstract][Full Text] [Related]
10. [Bone disorders in children with chronic renal insufficiency exposed to high ingestion of aluminum]. Gordillo-Paniagua G; Valencia-Mayoral P; Mercado L; Medina-Mercado M Bol Med Hosp Infant Mex; 1990 May; 47(5):336-41. PubMed ID: 2390188 [TBL] [Abstract][Full Text] [Related]
11. Loss of bone resulting from accumulation of aluminum in bone of patients undergoing dialysis. Faugere MC; Arnala IO; Ritz E; Malluche HH J Lab Clin Med; 1986 Jun; 107(6):481-7. PubMed ID: 3486929 [TBL] [Abstract][Full Text] [Related]
12. Effect of aluminum on bone and cell localization. Cournot-Witmer G; Plachot JJ; Bourdeau A; Lieberherr M; Jorgetti V; Mendes V; Halpern S; Hemmerle J; Drüeke T; Balsan S Kidney Int Suppl; 1986 Feb; 18():S37-40. PubMed ID: 3457993 [No Abstract] [Full Text] [Related]
19. The role of aluminium in experimental osteomalacia. Preliminary results: Aluminium content and bone mineralization. Costantini S; Bonucci E; Mocetti P; Ballanti P; Giordano R; Vernillo I; Ioppolo A; Mantovani A; Stasolla D Ann Ist Super Sanita; 1986; 22(2):689-95. PubMed ID: 3752831 [No Abstract] [Full Text] [Related]